Notice NOT-NS-24-102 from the NIH Guide for Grants and Contracts

Competitive: CK Group: CK Group are working in partnership with Nxera Pharma to recruit for a Cheminformatician to join their Computational Chemistry team. Applications are welcomed from candidates... Cambridge

Competitive: CK Group: CK Group are recruiting for a highly motivated Laboratory Automation Lead to join a leading biotechnological company in Newcastle. The successful candidate will have the... Newcastle upon Tyne

Funding Opportunity RFA-DA-25-085 from the NIH Guide for Grants and Contracts. The purpose of this concept is to facilitate the formation and maintenance of multidisciplinary research teams ready to employ epidemiological and/or etiological datasets and analyses to answer substance use prevention research questions and apply findings to intervention development or implementation. Projects supported through this concept will combine hands-on meeting formats, including both sandpit and hackathon approaches, with activities to sustain new research teams and networks, creating a foundational structure for research programs that have impact across disciplines.

Competitive: CK Group: CK Group are recruiting for a highly motivated Laboratory Automation Lead to join a leading biotechnological company in Newcastle. The successful candidate will have the... Newcastle upon Tyne

Southern Research: Director of Bioinformatics General Summary Southern Research (SR) is at a pivotal moment in its 82-year history. At the start of 2022, SR launched... Birmingham, Alabama

Notice NOT-OD-24-149 from the NIH Guide for Grants and Contracts

Competitive: CK Group: CK Group are working in partnership with Nxera Pharma UK Limited (formerly Sosei Heptares) to recruit an Associate Director, Quantitative Systems Pharmacology, Translational Medicine based... Cambridge

Funding Opportunity RFA-AG-25-028 from the NIH Guide for Grants and Contracts. This notice of funding opportunity (NOFO) invites applications from experienced investigators for mentored career enhancement awards for cross-disciplinary training to broaden and strengthen the investigator's capability to lead future comparative studies of the factors contributing to differences in life spans between human and nonhuman primate species. This opportunity will provide support for experienced investigators in pertinent fields to 1) augment or redirect their research program by acquiring expertise in other fields related to comparative primate research and aging and 2) develop collaborations with research fields with which they do not commonly interact. Pertinent fields of cross-training for this NOFO include comparative biology of aging, evolutionary genetics, evolutionary biology, anthropology, primatology, and human longevity studies. Specific emphasis for this NOFO will be on cross-training independent investigators in a substantially different area of study than their current field of study in one or more of the above scientific disciplines. An academic rank of associate or full professor, or the equivalent in non-academic research settings, is required for eligibility for this award.

Funding Opportunity PA-24-248 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity Announcement (NOFO), issued by the National Institutes of Health (NIH) invites eligible United States small businesses to submit Small Business Technology Transfer (STTR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH awarding components identified in this NOFO are encouraged to submit STTR grant applications in response to identified topics (see SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA). This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.

Funding Opportunity PA-24-247 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity Announcement (NOFO), issued by the National Institutes of Health (NIH) invites eligible United States small businesses to submit Small Business Technology Transfer (STTR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH awarding components identified in this NOFO are encouraged to submit STTR grant applications in response to identified topics (see SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA). This Parent Funding Opportunity Announcement does not accept clinical trials.

Funding Opportunity PA-24-246 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity Announcement (NOFO), issued by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) invites eligible United States small businesses to submit Small Business Innovation Research (SBIR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH and CDC awarding components identified in this NOFO are encouraged to submit SBIR grant applications in response to identified topics (see SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA). This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.

Notice NOT-HL-24-017 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-24-245 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO), issued by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA), invites eligible United States small businesses to submit Small Business Innovation Research (SBIR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH, CDC, and FDA awarding components identified in this NOFO are encouraged to submit SBIR grant applications in response to identified topics (see SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA). This Parent Funding Opportunity Announcement does not accept clinical trials.

Notice NOT-HL-24-016 from the NIH Guide for Grants and Contracts

Notice NOT-LM-24-002 from the NIH Guide for Grants and Contracts

Notice NOT-CA-24-070 from the NIH Guide for Grants and Contracts

GBP75000 - GBP90000 per year: Immunocore: Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new Oxford, England

Notice NOT-CA-24-077 from the NIH Guide for Grants and Contracts

Notice NOT-HD-24-026 from the NIH Guide for Grants and Contracts